Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. Cash on Hand 2009–2025
Protalix Biotherapeutics Inc. annual cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Protalix Biotherapeutics Inc. cash on hand as of December 31, 2025: 14.7M, a 25.71% decrease year-over-year.
- Protalix Biotherapeutics Inc. cash on hand for 2025 were 14.7M, a 25.71% decrease from 2024.
- Protalix Biotherapeutics Inc. cash on hand for 2024 were 19.8M, a 16.39% decrease from 2023.
- Protalix Biotherapeutics Inc. cash on hand for 2023 were 23.6M, a 38.12% increase from 2022.
- Protalix Biotherapeutics Inc. cash on hand for 2022 were 17.1M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Protalix Biotherapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $15 |
| 2024 | $20 |
| 2023 | $24 |
| 2022 | $17 |
| 2021 | $39 |
| 2020 | $18 |
| 2019 | $18 |
| 2018 | $38 |
| 2017 | $51 |
| 2016 | $63 |
| 2015 | $76 |
| 2014 | $55 |
| 2013 | $86 |
| 2012 | $52 |
| 2011 | $27 |
Protalix Biotherapeutics Inc. Cash on Hand — FAQ
Protalix Biotherapeutics Inc. (PLX) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLX's cash on hand history?
The chart and table above show Protalix Biotherapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.